$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Targeting tubulin polymerization by novel 7-aryl-pyrroloquinolinones: Synthesis, biological activity and SARs 원문보기

European journal of medicinal chemistry, v.143, 2018년, pp.244 - 258  

Bortolozzi, Roberta (Department of Woman's and Child's Health, University of Padova, Laboratory of Oncohematology, 35128 Padova, Italy) ,  Mattiuzzo, Elena (Department of Woman's and Child's Health, University of Padova, Laboratory of Oncohematology, 35128 Padova, Italy) ,  Dal Pra, Matteo (Department of Pharmaceutical and Pharmacological Sciences, University of Padova, 35131 Padova, Italy) ,  Sturlese, Mattia (Department of Pharmaceutical and Pharmacological Sciences, University of Padova, 35131 Padova, Italy) ,  Moro, Stefano (Department of Pharmaceutical and Pharmacological Sciences, University of Padova, 35131 Padova, Italy) ,  Hamel, Ernest (Screening Technologies Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, Frederick National Laboratory for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD 21702, USA) ,  Carta, Davide (Department of Pharmaceutical and Pharmacological Sciences, University of Padova, 35131 Padova, Italy) ,  Viola, Giampietro (Department of Woman's and Child's Health, University of Padova, Laboratory of Oncohematology, 35128 Padova, I) ,  Ferlin, Maria Grazia

Abstract AI-Helper 아이콘AI-Helper

Abstract Earlier studies had confirmed that the 7-phenylpyrroloquinolinone (7-PPyQ) nucleus was an important scaffold for new chemotherapeutic drugs targeting microtubules. For wide-ranging SARs, a series of derivatives were synthesized through a robust procedure. For comparison with the reference ...

주제어

참고문헌 (36)

  1. Nat. Rev. Drug Discov. Dumontet 9 790 2010 10.1038/nrd3253 Microtubule-binding agents: a dynamic field of cancer therapeutics 

  2. Pharm. Res. Lu 29 2943 2012 10.1007/s11095-012-0828-z An overview of tubulin inhibitors that interact with the colchicine binding site 

  3. J. Med. Chem. Gasparotto 49 1910 2006 10.1021/jm0510676 Synthesis and biological activity of 7-phenyl-6,9-dihydro-3H-pyrrolo[3,2-f]quinolin-9-ones: a new class of antimitotic agents devoid of aromatase activity 

  4. J. Med. Chem. Gasparotto 50 5509 2007 10.1021/jm070534b 3-Substituted 7-phenyl-pyrroloquinolinones show potent cytotoxic activity in human cancer cell lines 

  5. ChemMedChem. Ferlin 5 1373 2010 10.1002/cmdc.201000180 Synthesis and in vitro evaluation of 3H-pyrrolo[3,2-f]-quinolin-9-one derivatives that show potent and selective anti-leukemic activity 

  6. Biochem. Pharmacol. Viola 83 16 2012 10.1016/j.bcp.2011.09.017 MG-2477, a new tubulin inhibitor, induces autophagy through inhibition of the Akt/mTOR pathway and delayed apoptosis in A549 cells 

  7. Curr. Top. Med. Chem. Carta 2322 2322 2014 10.2174/1568026614666141127120421 An overview on 2-arylquinolin-4(1H)-ones and related structures as tubulin polymerisation inhibitors 

  8. J. Med. Chem. Carta 58 7991 2015 10.1021/acs.jmedchem.5b00805 Novel 3-substituted 7-phenylpyrrolo[3,2-f]quinolin-9(6H)-ones as single entities with multitarget Antiproliferative Activity 

  9. Eur. J. Med. Chem. Carta 127 643 2017 10.1016/j.ejmech.2016.10.026 Synthesis, structure-activity relationships and biological evaluation of 7-phenyl-pyrroloquinolinone 3-amide derivatives as potent antimitotic agents 

  10. Chem. Pharm. Bull. (Tokyo) Nakano 30 2590 1982 10.1248/cpb.30.2590 Studies on ketene and its derivatives. CX. Synthesis of 1,3-dimethoxyfluoren-9-ones 

  11. J. Med. Chem. Romagnoli 57 6795 2014 10.1021/jm5008193 Synthesis, antimitotic and antivascular activity of 1-(3’,4’, 5’-trimethoxybenzoyl)-3-arylamino-5-amino-1,2,4-triazoles 

  12. Cell Biochem. Biophys Hamel 38 1 2003 10.1385/CBB:38:1:1 Evaluation of antimitotic agents by quantitative comparisons of their effects on the polymerization of purified tubulin 

  13. Mol. Pharmacol. Verdier-Pinard 53 62 1998 10.1124/mol.53.1.62 Structure-activity analysis of the interaction of curacin A, the potent colchicine site antimitotic agent, with tubulin and effects of analogs on the growth of MCF-7 breast cancer cells 

  14. Cancer Cell Weaver 8 7 2005 10.1016/j.ccr.2005.06.011 Decoding the links between mitosis, cancer, and chemotherapy: the mitotic checkpoint, adaptation, and cell death 

  15. Trends Cell Biol. Clarke 19 89 2009 10.1016/j.tcb.2008.12.003 Cell-cycle control in the face of damage - a matter of life or death 

  16. Apoptosis Vitale 12 155 2007 10.1007/s10495-006-0491-0 Combretastatin CA-4 and combretastatin derivative induce mitotic catastrophe dependent on spindle checkpoint and caspase-3 activation in non-small cell lung cancer cells 

  17. Apoptosis Cenciarelli 13 659 2008 10.1007/s10495-008-0200-2 The tubulin-depolymerising agent combretastatin-4 induces ectopic aster assembly and mitotic catastrophe in lung cancer cells H460 

  18. Apoptosis Tsujimoto 12 835 2007 10.1007/s10495-006-0525-7 Role of the mitochondrial membrane permeability transition in cell death 

  19. Protein Cell Xiong 5 737 2014 10.1007/s13238-014-0089-1 Mitochondria-mediated apoptosis in mammals 

  20. Curr. Protoc. Cytom. Chapter Lugli 7 2007 10.1002/0471142956.cy0732s41 Polychromatic analysis of mitochondrial membrane potential using JC-1 

  21. Biochim. Biophys. Acta - Bioenerg. Rovini 1807 679 2011 10.1016/j.bbabio.2011.01.001 Microtubule-targeted agents: when mitochondria become essential to chemotherapy 

  22. J. Med. Chem. Romagnoli 56 9296 2013 10.1021/jm4013938 Concise synthesis and biological evaluation of 2-aroyl-5-amino benzo[b]thiophene derivatives as a novel class of potent antimitotic agents 

  23. J. Med. Chem. Romagnoli 58 3209 2015 10.1021/acs.jmedchem.5b00155 Design, synthesis, in vitro, and in vivo anticancer and antiangiogenic activity of novel 3-arylaminobenzofuran derivatives targeting the colchicine site on tubulin 

  24. J. Exp. Med. Zamzami 182 367 1995 10.1084/jem.182.2.367 Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death 

  25. J. Biol. Chem. Cai 273 11401 1998 10.1074/jbc.273.19.11401 Jones, Superoxide in apoptosis. Mitochondrial generation triggered by cytochrome c loss 

  26. Biochem. Pharmacol. Nohl 69 719 2005 10.1016/j.bcp.2004.12.002 Staniek, Intracellular generation of reactive oxygen species by mitochondria 

  27. J. Leukoc. Biol. Rothe 47 440 1990 10.1002/jlb.47.5.440 Flow cytometric analysis of respiratory burst activity in phagocytes with hydroethidine and 2’,7’-dichlorofluorescin 

  28. EMBO J. Harley 29 2407 2010 10.1038/emboj.2010.112 Clarke, Phosphorylation of Mcl-1 by cdk1-cyclin B1 initiates its cdc20-dependent destruction during mitotic arrest 

  29. Nature Wertz 471 110 2011 10.1038/nature09779 Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7 

  30. Nat. Commun. Haschka 6 6891 2015 10.1038/ncomms7891 The NOXA-MCL1-BIM axis defines lifespan on extended mitotic arrest 

  31. FEBS J. Wang 283 102 2016 10.1111/febs.13555 Structures of a diverse set of colchicine binding site inhibitors in complex with tubulin provide a rationale for drug discovery 

  32. J. Mol. Model Stewart 13 1173 2007 10.1007/s00894-007-0233-4 Optimization of parameters for semiempirical methods V: modification of NDDO approximations and application to 70 elements 

  33. Chemical Computing Group (CCG) Inc 2016 Molecular Operating Environment (MOE) 

  34. Cuzzolin 9977 2015 Molecules. DockBench: an Integrated Informatic Platform Bridging the Gap between the Robust Validation of Docking Protocols and Virtual Screening Simulations.20 

  35. GOLD suite, Version 5.2 (Internet). Cambridge Crystallographic Data Centre: 12 Union Road, Cambridge CB2 1EZ, UK. Available from: http://www.ccdc.cam.ac.uk. 

  36. StarDrop Optibrium Ltd, 7221 Cambridge Research Park, Beach Drive, Cambridge, CB25 9TL, UK. http://www.optibrium.com/. 

관련 콘텐츠

오픈액세스(OA) 유형

GREEN

저자가 공개 리포지터리에 출판본, post-print, 또는 pre-print를 셀프 아카이빙 하여 자유로운 이용이 가능한 논문

섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로